secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001140361-23-051737
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis Q3 revenue up 17% YoY to $2.4M; net loss narrows to $3.4M
------------------------------------------------------------------

- Revenue of $2.4M (+17% YoY); circuit sales driving growth with 26% increase in therapy utilization.
- Gross margin 57.3% vs 61.0% YoY due to lower console volumes; disposable margins at 74.0%.
- Net loss $3.4M ($1.81 loss per share) vs $3.9M ($36.72) YoY; lower expenses and higher share count.
- Cash $4.9M, no debt; closed $2.25M public offering on Oct 17 for additional capital.
- Collaborations with SeaStar (pediatric SCD device distribution) and DaVita (pilot phase) progressing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123051737/0001140361-23-051737-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123051737/ef20014069_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-051737

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer